25 Jun 2021 17:25
Â
Renalytix plcÂ
Â
("Renalytix" or the "Company")
Â
Director/PDMR Dealing
Â
The Company was informed that today, Fergus Fleming, Chief Technology Officer, completed the sale of 15,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 1075 pence per share.
Â
Following completion of the sale, Fergus Fleming is interested in 569,481 Ordinary Shares representing 0.79% of the current issued share capital of the Company.
Â
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Â
1  | Details of the person discharging managerial responsibilities / person closely associated  | ||||
a)  | Name   |  Fergus Fleming | |||
2  | Reason for the notification  | ||||
a)  | Position/status   | Chief Technology Officer | |||
b)  | Initial notification /Amendment   | Initial Notification | |||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | ||||
a)  | Name   | Renalytix plc | |||
b) Â | LEI Â Â | 213800NTOH3FK3WER551 | |||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   | ||||
a)  | Description of the financial instrument, type of instrument | Ordinary shares of £0.0025 each | |||
Identification code | GB00BYWL4Y04 Â | ||||
 | |||||
b)  | Nature of the transaction   | Sale of shares | |||
c) | Currency | GBP | |||
d) Â | Price(s) and volume(s) | Â | Â | Â | Â |
 | Price(s) | Volume(s) |  | ||
 | £10.75 | 15,000 |  | ||
 |  |  |  | ||
e) Â | Aggregated information | ||||
- Aggregated volume | 15,000 | ||||
- Price | £161,250.00 | ||||
f)  | Date of the transaction   | 25 June 2021 | |||
g)  | Place of the transaction   | London Stock Exchange | |||
Â
Â
Â
Renalytix Plc (RENX)